Immutep Ltd Adr Stock Today
| IMMP Stock | USD 2.32 0.07 3.11% |
Performance4 of 100
| Odds Of DistressLess than 39
|
Immutep is selling at 2.32 as of the 23rd of April 2024; that is 3.11% increase since the beginning of the trading day. The stock's last reported lowest price was 2.2. Immutep has about a 39 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Immutep Ltd ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of May 2022 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 17th of April 2012 | Category Healthcare | Classification Health Care |
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. Immutep Limited was incorporated in 1987 and is headquartered in Sydney, Australia. Immutep operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.. The company has 118.88 M outstanding shares of which 1.26 M shares are currently shorted by private and institutional investors with about 7.3 trading days to cover. More on Immutep Ltd ADR
Moving together with Immutep Stock
| 0.61 | OPT | Opthea | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Immutep Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Immutep's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Immutep or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Executive Director | Marc Voigt | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Immutep report their recommendations after researching Immutep's financial statements, talking to executives and customers, or listening in on Immutep's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Immutep Ltd ADR. The Immutep consensus assessment is calculated by taking the average forecast from all of the analysts covering Immutep. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of Immutep's profitability, liquidity, and operating efficiency, Immutep Ltd ADR is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Immutep Ltd ADR is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immutep's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Immutep's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Immutep's financial leverage. It provides some insight into what part of Immutep's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immutep Ltd ADR (IMMP) is traded on NASDAQ Exchange in USA. It is located in Australia Square, Sydney, NSW, Australia, 2000 and employs 14 people. Immutep is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 275.81 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Immutep's market, we take the total number of its shares issued and multiply it by Immutep's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Immutep Ltd ADR conducts business under Biotechnology sector and is part of Health Care industry. The entity has 118.88 M outstanding shares of which 1.26 M shares are currently shorted by private and institutional investors with about 7.3 trading days to cover.
Immutep Ltd ADR currently holds about 80 M in cash with (35.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92.
Check Immutep Probability Of Bankruptcy
Ownership AllocationImmutep Ltd ADR has a total of 118.88 Million outstanding shares. Roughly 97.0 (percent) of Immutep outstanding shares are held by general public with 0.01399999999999999 % owned by insiders and only 2.76 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Immutep Ownership Details
Immutep Stock Price Odds Analysis
In regard to a normal probability distribution, the odds of Immutep jumping above the current price in 90 days from now is about 63.06%. The Immutep Ltd ADR probability density function shows the probability of Immutep stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.3269. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Immutep will likely underperform. Additionally, immutep Ltd ADR has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Immutep to move above the current price in 90 days from now is about 63.06 (This Immutep Ltd ADR probability density function shows the probability of Immutep Stock to fall within a particular range of prices over 90 days) .
Immutep Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Immutep that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Immutep's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Immutep's value.| Instituion | Recorded On | Shares | |
| Rhumbline Advisers | 2023-12-31 | 26.9 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 23.5 K | |
| Geode Capital Management, Llc | 2023-12-31 | 18.7 K | |
| Virtu Financial Llc | 2023-12-31 | 12.2 K | |
| Citadel Advisors Llc | 2023-09-30 | 4.3 K | |
| Cutler Group Lp | 2023-12-31 | 3.8 K | |
| Group One Trading, Lp | 2023-12-31 | 3.7 K | |
| Ronald Blue Trust, Inc. | 2023-12-31 | 196 | |
| Tower Research Capital Llc | 2023-12-31 | 100.0 | |
| Blackrock Inc | 2023-12-31 | 646.2 K | |
| Oracle Investment Management Inc | 2023-12-31 | 516.4 K |
Immutep Historical Income Statement
Immutep Ltd ADR Income Statement is one of the three primary financial statements used for reporting Immutep's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Immutep Ltd ADR revenue and expense. Immutep Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Immutep's Depreciation And Amortization is relatively stable compared to the past year. As of 04/23/2024, Other Operating Expenses is likely to grow to about 54.3 M, though Operating Income is likely to grow to (38.4 M). View More FundamentalsImmutep Stock Against Markets
Picking the right benchmark for Immutep stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Immutep stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Immutep is critical whether you are bullish or bearish towards Immutep Ltd ADR at a given time. Please also check how Immutep's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Immutep without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Immutep Corporate Directors
Immutep corporate directors refer to members of an Immutep board of directors. The board of directors generally takes responsibility for the Immutep's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Immutep's board members must vote for the resolution. The Immutep board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Frederic MD | Chief Director | Profile | |
| Pete Meyers | Non-Executive Director | Profile | |
| Russell Howard | Non-Executive Director | Profile | |
| Grant Chamberlain | Non-Executive Director | Profile |
How to buy Immutep Stock?
Before investing in Immutep, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Immutep. To buy Immutep stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Immutep. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Immutep stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Immutep Ltd ADR stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Immutep Ltd ADR stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Immutep Ltd ADR, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Immutep Stock please use our How to Invest in Immutep guide.
Already Invested in Immutep Ltd ADR?
The danger of trading Immutep Ltd ADR is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Immutep is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Immutep. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Immutep Ltd ADR is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Immutep Ltd ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Immutep Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Immutep Ltd Adr Stock. Highlighted below are key reports to facilitate an investment decision about Immutep Ltd Adr Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Immutep Stock analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Immutep's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immutep. If investors know Immutep will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immutep listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.25) | Revenue Per Share 0.04 | Quarterly Revenue Growth 0.252 | Return On Assets (0.26) | Return On Equity (0.42) |
The market value of Immutep Ltd ADR is measured differently than its book value, which is the value of Immutep that is recorded on the company's balance sheet. Investors also form their own opinion of Immutep's value that differs from its market value or its book value, called intrinsic value, which is Immutep's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immutep's market value can be influenced by many factors that don't directly affect Immutep's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immutep's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immutep is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immutep's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.